Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1717402

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the health benefits of the proposed generational ban on smoking.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL4567
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom and causes around one in four UK cancer deaths. Smoking is one of the most important preventable causes of disparities in health, and a significant contributor to the gap in life expectancy.</p><p>Reduced smoking rates lead to fewer people dying from smoking-related diseases and fewer children exposed to second-hand smoke or living in smoking-induced poverty. There are four major diseases that together account for almost 60% of all ill health and early deaths attributable to smoking: chronic obstructive pulmonary disease; coronary heart disease; lung cancer; and strokes. By 2075, our modelling suggests that between 48,000 and 115,000 cases of these diseases would be avoided, improving people’s lives and avoiding the pain of loss for families.</p><p>Smoking also costs society £21.8 billion a year and puts a huge burden on the National Health Service. Our Impact Assessment on the Tobacco and Vapes Bill found that there would be savings of more than £2 billion, in 2019 prices, in reduced healthcare usage costs over 30 years from 2027. Health and economic gains are expected further in the future, saving the health and care system up to £18 billion and boosting the economy by up to £85 billion by 2075, cumulatively and undiscounted. Someone who avoids a smoking-related death can be expected to live eight to nine years longer as a result of this change, as set out in the command paper from October 2023.</p> answering member printed Lord Markham grouped question UIN HL4568 question first answered 23/05/2024 12:04:29 answering member 4948 label Biography information for Lord Markham
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1717403

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what estimate they have made of the cost saving to the NHS of the proposed generational ban on smoking from 2027 onwards.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL4568
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom and causes around one in four UK cancer deaths. Smoking is one of the most important preventable causes of disparities in health, and a significant contributor to the gap in life expectancy.</p><p>Reduced smoking rates lead to fewer people dying from smoking-related diseases and fewer children exposed to second-hand smoke or living in smoking-induced poverty. There are four major diseases that together account for almost 60% of all ill health and early deaths attributable to smoking: chronic obstructive pulmonary disease; coronary heart disease; lung cancer; and strokes. By 2075, our modelling suggests that between 48,000 and 115,000 cases of these diseases would be avoided, improving people’s lives and avoiding the pain of loss for families.</p><p>Smoking also costs society £21.8 billion a year and puts a huge burden on the National Health Service. Our Impact Assessment on the Tobacco and Vapes Bill found that there would be savings of more than £2 billion, in 2019 prices, in reduced healthcare usage costs over 30 years from 2027. Health and economic gains are expected further in the future, saving the health and care system up to £18 billion and boosting the economy by up to £85 billion by 2075, cumulatively and undiscounted. Someone who avoids a smoking-related death can be expected to live eight to nine years longer as a result of this change, as set out in the command paper from October 2023.</p> answering member printed Lord Markham grouped question UIN HL4567 question first answered 23/05/2024 12:04:29 answering member 4948 label Biography information for Lord Markham
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1717404

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they have had with (1) the British Medical Association, and (2) other health organisations, concerning the proposed generational ban on smoking.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL4569
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department meets with the British Medical Association (BMA) on a range of issues. Along with other health stakeholders, the BMA was invited to provide views via the Creating a smokefree generation and tackling youth vaping consultation, and to take part in ministerial roundtables during the development of our Smokefree Generation policy.</p><p>Ministers and officials regularly meet with a number of health organisations to discuss the Smokefree Generation policy. These include royal colleges, non-government organisations, and academics. All senior officials’ and ministerial external meetings are published on the GOV.UK website, in an online only format.</p> answering member printed Lord Markham question first answered 23/05/2024 12:22:20 answering member 4948 label Biography information for Lord Markham
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1717405

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco and Vapes Bill
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what data they collected on other countries that have restricted smoking when drafting the Tobacco and Vapes Bill.
tabling member printed	Lord Bourne of Aberystwyth
uin	HL4570
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom and causes around one in four UK cancer deaths. It also costs society £21.8 billion a year and puts a huge burden on the National Health Service. The latest estimates from Action on Smoking and Health put the cost of smoking to the NHS and social care at £3 billion a year.</p><p>As part of our impact assessment, we reviewed evidence and data from a range of countries. This included modelling from New Zealand, Singapore, and the Solomon Islands on the estimated impact of a smokefree generation policy on smoking prevalence, smoking attributable mortality, and other health impacts. We also considered evidence and data from countries that have already implemented an increase in the age of sale for tobacco to a particular age. For example, we analysed data and evidence from the United States on the impact that raising the age of sale from 18 to 21 years old had on smoking prevalence.</p><p>This was in addition to considering evidence and data from the UK on the impact that previous increases in the age of sale for tobacco have had on smoking prevalence. A copy of our Tobacco and Vapes Bill - impact assessment is attached.</p> answering member printed Lord Markham question first answered 20/05/2024 15:06:35 answering member 4948 label Biography information for Lord Markham attachment 1 file name tobacco-vapes-bill-impact-assessment.pdf title tobacco-vapes-bill-impact-assessment
tabling member	4282 label Biography information for Lord Bourne of Aberystwyth

1717419

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Abortion: Telemedicine
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 9 May (HL4286), whether they have issued guidance to telemedicine providers about complying with the prohibition of termination of pregnancy at gestations over 10 weeks outside a National Health Service facility or an approved place; and if not, why.
tabling member printed	Lord Jackson of Peterborough
uin	HL4584
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>No specific guidance has been issued, however, all abortion providers are aware that termination of pregnancy in England and Wales can only be provided within the legal framework laid down in the Abortion Act 1967.</p><p>The legal framework for home use of early medical abortion pills is set out in the Department’s guidance, Abortion: procedures for the approval of independent sector places for termination of pregnancy (abortion) in England. This guidance applies to independent sector abortion clinics and states that the Abortion Act 1967 allows women having an abortion during the first 10 weeks of pregnancy, specifically up to nine weeks and six days gestation, to take one or both medicines for an early medical abortion at home. It also highlights that women having an early medical abortion at home should be given information on the implications, health and otherwise, of taking the abortion medicine beyond the legal limit of nine weeks and six days gestation.</p><p>In addition, the National Institute for Health and Care Excellence’s guideline on abortion care, to which all abortion providers are expected to have due regard, highlights that women who are having a medical abortion and will be taking the first pill, mifepristone, up to and including nine weeks six days gestation, can be offered the option of expulsion at home.</p> answering member printed Lord Markham question first answered 23/05/2024 14:22:17 answering member 4948 label Biography information for Lord Markham
tabling member	1551 label Biography information for Lord Jackson of Peterborough

1717421

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how many people diagnosed with cancer underwent a needs assessment and were given a personalised care and support plan in (1) 2021, (2) 2022, and (3) 2023.
tabling member printed	Lord Kempsell
uin	HL4586
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The information is not available, as the data is not collected in the format requested.</p> answering member printed Lord Markham grouped question UIN HL4587 question first answered 21/05/2024 11:09:03 answering member 4948 label Biography information for Lord Markham
tabling member	4988 label Biography information for Lord Kempsell

1717422

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how many people who completed cancer treatment were offered an 'end of treatment summary' in (1) 2021, (2) 2022, and (3) 2023.
tabling member printed	Lord Kempsell
uin	HL4587
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The information is not available, as the data is not collected in the format requested.</p> answering member printed Lord Markham grouped question UIN HL4586 question first answered 21/05/2024 11:09:03 answering member 4948 label Biography information for Lord Markham
tabling member	4988 label Biography information for Lord Kempsell

1717423

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they will take to ensure equity and quality in care and support across the entire cancer pathway, including (1) fairness and equity in diagnostics, (2) on time treatment, and (3) patients being offered conversations about the additional care and support they may need.
tabling member printed	Lord Kempsell
uin	HL4588
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The Department is taking steps to ensure equity and quality in care and support for patients is available across the entire cancer pathway. Reducing inequalities and variation in cancer diagnosis and treatment are a priority for the Government, as is increasing early cancer diagnosis, as this is a key contributor to reducing cancer health inequalities. The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity. As part of this, we are increasing diagnostic capacity by rolling out community diagnostic centres across England, with capacity prioritised for cancer checks. Additionally, and as outlined in the 2024/25 NHS England Planning Guidance, NHS England is providing over £266 million in cancer service development funding to Cancer Alliances, to support delivery of the operational priorities for cancer.</p><p>The Department's ministers and officials frequently meet with key stakeholders within the cancer community, including discussions on support for patients and their families. The National Health Service provides personalised cancer care and support plans, to support both patients and their families at all stages of their cancer journey. This is being delivered in line with the NHS Comprehensive Model for Personalised Care, empowering people to manage their care and the impact of their cancer, and maximise the potential of digital and community-based support.</p><p>General practice surgeries also conduct cancer care reviews at regular intervals after cancer diagnosis, to offer support with any needs patients may have. This includes providing access to other specialist-led services who work alongside patients’ medical teams, to support patients and their families, such as counsellors, rehabilitation specialists, or social prescribers, who can connect you to community groups or services for more support.</p><p>NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities in England are met, including for cancer patients. NHS England provides access to a personal health budget, which is an amount of NHS money that is allocated to support the health and wellbeing needs of a patient, if eligible.</p> answering member printed Lord Markham question first answered 20/05/2024 15:19:21 answering member 4948 label Biography information for Lord Markham
tabling member	4988 label Biography information for Lord Kempsell

1717431

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they plan to generate real-world data on any future RSV immunisation programme for older adults and infants and, if so, how such data would be used to inform future eligibility.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4596
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The UK Health Security Agency monitors national immunisation programmes in England, and will monitor the implementation of any future protection immunisation programmes for older adults and infants. This includes immunisation coverage, immunisation effectiveness at preventing disease, including the duration of the protective effect, the overall impact of the immunisation programme, and any safety signals. This real-world data will be shared with the Joint Committee on Vaccination and Immunisation and the Department, to inform future policy including future eligibility.</p> answering member printed Lord Markham question first answered 23/05/2024 12:22:41 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717432

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to review eligibility for any future RSV immunisation programme, and whether such a review would be based on timing or on assessment of data.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4597
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Government have made a policy decision on the eligibility of a potential respiratory snncytial virus (RSV) programme, which is in line with the Joint Committee of Vaccination and Immunisation’s (JCVI) September 2023 advice.</p><p>When a new immunisation programme is introduced, policy decisions are made about who the National Health Service will offer the immunisation to. These decisions are based on the advice and recommendations of the JCVI. The eligibility of an immunisation programme is not reviewed in a time-based manner, although the JCVI keeps all immunisation programmes and advice under review and can update its advice based on new and emerging data.</p> answering member printed Lord Markham question first answered 23/05/2024 14:34:14 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick